Viewing Study NCT00095550


Ignite Creation Date: 2025-12-24 @ 5:25 PM
Ignite Modification Date: 2026-02-21 @ 3:47 PM
Study NCT ID: NCT00095550
Status: COMPLETED
Last Update Posted: 2011-04-15
First Post: 2004-11-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Irbesartan/Hydrochlorothiazide (HCTZ) Combination Therapy for Patients With Moderate Hypertension
Sponsor: Bristol-Myers Squibb
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hypertension View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Moderate Hypertension View